| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $105.5M | — | +1.2% |
| Cost of Revenue | $43.2M | — | +6.2% |
| Gross Profit | $62.3M | — | -2.0% |
| R&D Expense | $571K | — | — |
| SG&A Expense | $17.9M | — | +1.8% |
| Operating Income | $4.8M | — | -48.7% |
| Pre-tax Income | $2.3M | — | -69.6% |
| Income Tax | $949K | — | -77.7% |
| Net Income | $1.4M | — | -59.4% |
| EPS (Basic) | $0.01 | — | -75.0% |
| EPS (Diluted) | $0.01 | — | -75.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $132.2M | +10.2% | +7.8% |
| Accounts Receivable | $95.7M | -30.0% | +28.8% |
| Current Assets | $274.1M | -8.7% | +16.6% |
| Total Assets | $397.1M | -6.1% | +15.8% |
| Current Liabilities | $324.4M | -6.6% | +9.9% |
| Long-term Debt | $56.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.5M | — | -27.2% |
| Investing Cash Flow | -$648K | — | +27.6% |
| Financing Cash Flow | -$10.6M | — | -933.2% |
| -30.7% |
| Total Liabilities | $419.7M | -6.8% | +3.2% |
| Stockholders' Equity | -$22.6M | +16.5% | +64.6% |